The SAFEST Study: Survey on Antiplatelets in Flow Diversion for Aneurysm Endovascular Treatment
Antiplatelet treatment strategies following flow diversion procedures vary globally, with a growing interest in alternative agents and a willingness to participate in future trials. Standardization efforts and further investigation are warranted for optimizing neurointerventional outcomes.
Authors
- Jessica Jesser (ORCID: https://orcid.org/0000-0002-1236-8828)
- Gabriele Maliandi
- Dominik F. Vollherbst (ORCID: https://orcid.org/0000-0002-8992-4757)
- Martin Bendszus (ORCID: https://orcid.org/0000-0002-9094-6769)
- Markus Alfred Möhlenbruch (ORCID: https://orcid.org/0000-0002-5075-704X)
- Adam Andrew Dmytriw (ORCID: https://orcid.org/0000-0003-0131-5699)
- Thanh N. Nguyen (ORCID: https://orcid.org/0000-0002-2810-1685)
- Hiroshi Yamagami (ORCID: https://orcid.org/0000-0002-4224-8130)
- Sophia Hohenstatt (ORCID: https://orcid.org/0000-0003-0951-3948)
- Mai Duy Ton (ORCID: https://orcid.org/0000-0002-7540-0979)
- Zhongrong Miao
Institutions
- Brigham and Women's Hospital (US)
- Boston Medical Center (US)
- Harvard University (US)
- Capital Medical University (CN)
- Hanoi Medical University (VN)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Beijing Tian Tan Hospital (CN)
- Massachusetts General Hospital (US)
- Osaka National Hospital (JP)
- Bạch Mai Hospital (VN)
Publication Details
- Journal
- Stroke Vascular and Interventional Neurology
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1161/svin.124.001464
- Citations
- 6
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.41